Select Page

AMR Stakeholder Network

Call for good practices to tackle antimicrobial resistance

Deadline | 29 January 2021 17:00 CET

The facts about AMR

Antimicrobial resistance (AMR) is a serious global health threat. Each year, 750,000 people die globally as a consequence of drug-resistant bacteria – with 33,000 annual deaths in Europe. The World Bank estimates that AMR could push 28 million people into extreme poverty by 2050 with an annual economic impact of more than USD $1 trillion after 2030.

Superbugs cost the life of nearly 90 people every day in the EU and the EEA. A serious threat to patient safety, AMR crosses national borders and endangers many healthcare interventions, including life-saving surgical procedures and cancer treatments. The development and spread of multi-drug resistance has far-reaching and potentially life-threatening consequences for humans, animals and the environment, and jeopardises the achievement of the Sustainable Development Goals (SDGs).

About the AMR Stakeholder Network: Transforming commitments to action

The AMR Stakeholder Network is the largest civil society-led AMR coalition active at the European and national level, with members in over 13 European countries.

The Network activities are concentrated around its 2019 Roadmap for Action on Antimicrobial Resistance, which outlines five key strategies and targets to tackle AMR and supports the implementation of the One Health Action Plan:

1. Set targets and performance indicators;
2 Help countries mobilise resources for better implementation of national AMR policies;
3. Close the existing collaboration gap between civil society and EU policy-makers;
4 .Put prevention at the heart of AMR policy-making;
5. Tackle the environmental dimension of AMR in the framework of the European Green Deal.

As one way of turning the commitments of the Roadmap into concrete action, the Stakeholder Network is compiling a collection of case studies to highlight good practices in One Health areas.

Finding the Hidden Invention: (re-)discovering existing good practices

Can you help the AMR Stakekolder Network collect examples of good practices in tackling AMR, to support our advocacy work for greater coordinated action at EU and national level?

Actual action, pragmatic interventions and implemented practices have the clear potential to reduce or slow down the development of resistant bacteria. Local circumstances, promising national policies and individual initiatives could lead to significant improvements in the field.

Identifying those existing practices, bringing them to light and giving them large visibility at European level will help make the principles in the Roadmap tangible and will fuel further advocacy efforts aiming at making those practices known, recognised and implemented throughout Europe.

Collecting the case studies could help to contribute to the strengthening of Europe’s AMR “safety net” in the aftermath of the Coronavirus pandemic. This will become even more important given that one of the key lessons of the crisis is that Europe is lacking a coordinated, harmonised pandemic surveillance and response mechanism in the face of serious cross-border threats to healthcare.

Criteria for submitting your AMR good practice

AMR can only be addressed through a multi-disciplinary approach, integrating human and animal health as well as environmental perspectives. EU and national decision-makers must therefore adopt a true ‘One Health’ approach in their actions to tackle AMR. Therefore:

1. The good practice should fall into one of the five areas of the AMR Stakeholder Network 2019 Roadmap for Action on Antimicrobial Resistance

2. The good practice can be for the purpose of tackling AMR in human, animal and environmental health. If a practice is relevant for more than one of these areas, this should be made clear when submitting the example.

Submissions for inclusion into an “AMR good practice” publication will be evaluated according to criteria such as:

  • how how far they might achieve one or more of the aims of the Roadmap
  • how many people have been reached by the best practice
  • how it has added value to existing initiatives or makes a unique contribution to tackling AMR
  • how it supports tackling AMR amongst a particular vulnerable group

Submissions will be evaluated by a Selection Committee made up of members of the AMR Stakeholder Network with expertise in the different One Health areas of AMR.

How to submit your AMR good practice

Submissions can be made by completing the form here.

Any attachments in support of your submission can be sent to Zoltàn Massay-Kosubek at zoltan@epha.org. Please contact him if you have any questions about the process.

Closing Date

Your AMR good practice should be submitted by 29 January 2021 | 17:00 CET